BR8907831A - Processo para preparar composicao de glicosamino glicosida,composicao de glicosamino glicosida,anti-corpos,composto,composicao farmaceutica,processo para diagnosticar deficiencia ou excesso de glicosamino glicosida antiproliferativa em paciente mamifero,processo para analisar nivel de fator antiproliferativo em amostra biologica,e processo para separar ions organicos de ions inorganicos - Google Patents

Processo para preparar composicao de glicosamino glicosida,composicao de glicosamino glicosida,anti-corpos,composto,composicao farmaceutica,processo para diagnosticar deficiencia ou excesso de glicosamino glicosida antiproliferativa em paciente mamifero,processo para analisar nivel de fator antiproliferativo em amostra biologica,e processo para separar ions organicos de ions inorganicos

Info

Publication number
BR8907831A
BR8907831A BR898907831A BR8907831A BR8907831A BR 8907831 A BR8907831 A BR 8907831A BR 898907831 A BR898907831 A BR 898907831A BR 8907831 A BR8907831 A BR 8907831A BR 8907831 A BR8907831 A BR 8907831A
Authority
BR
Brazil
Prior art keywords
emphasis
antiprolytic
glycosamino
antiproliferative
glycoside composition
Prior art date
Application number
BR898907831A
Other languages
English (en)
Inventor
Brian K Brandley
Lun H Lam
Roger A Laine
Original Assignee
Glycomed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycomed Inc filed Critical Glycomed Inc
Publication of BR8907831A publication Critical patent/BR8907831A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BR898907831A 1988-12-15 1989-12-14 Processo para preparar composicao de glicosamino glicosida,composicao de glicosamino glicosida,anti-corpos,composto,composicao farmaceutica,processo para diagnosticar deficiencia ou excesso de glicosamino glicosida antiproliferativa em paciente mamifero,processo para analisar nivel de fator antiproliferativo em amostra biologica,e processo para separar ions organicos de ions inorganicos BR8907831A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28554688A 1988-12-15 1988-12-15
US07/400,661 US5032679A (en) 1988-12-15 1989-08-31 Heparin fragments as inhibitors of smooth muscle cell proliferation
PCT/US1989/005559 WO1990006755A1 (en) 1988-12-15 1989-12-14 Heparin fragments as inhibitors of smooth muscle cell profileration

Publications (1)

Publication Number Publication Date
BR8907831A true BR8907831A (pt) 1991-10-22

Family

ID=26963247

Family Applications (1)

Application Number Title Priority Date Filing Date
BR898907831A BR8907831A (pt) 1988-12-15 1989-12-14 Processo para preparar composicao de glicosamino glicosida,composicao de glicosamino glicosida,anti-corpos,composto,composicao farmaceutica,processo para diagnosticar deficiencia ou excesso de glicosamino glicosida antiproliferativa em paciente mamifero,processo para analisar nivel de fator antiproliferativo em amostra biologica,e processo para separar ions organicos de ions inorganicos

Country Status (8)

Country Link
US (1) US5032679A (pt)
EP (1) EP0448637A4 (pt)
JP (1) JPH04503950A (pt)
AU (1) AU634199B2 (pt)
BR (1) BR8907831A (pt)
CA (1) CA2005739A1 (pt)
DK (1) DK115791A (pt)
WO (1) WO1990006755A1 (pt)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5827826A (en) * 1986-03-03 1998-10-27 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compositions of human endothelial cell growth factor
US5380716A (en) * 1988-12-15 1995-01-10 Glycomed, Inc. Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation
US5340932A (en) * 1989-08-18 1994-08-23 Ajorca S.A. Substances with heparin-like structure and their method of production
WO1991006303A1 (en) * 1989-10-27 1991-05-16 Case Western Reserve University Inhibition of cell growth by keratan sulfate, chondroitin sulfate, dermatan sulfate and other glycans
US5280016A (en) * 1991-03-29 1994-01-18 Glycomed Incorporated Non-anticoagulant heparin derivatives
AU1680692A (en) * 1991-03-29 1992-11-02 Glycomed Incorporated Modulation of tpa activity by heparin fragments
US5250519A (en) * 1991-03-29 1993-10-05 Glycomed Incorporated Non-anticoagulant heparin derivatives
US5707973A (en) * 1991-04-23 1998-01-13 Rhone-Poulenc Rorer S.A. Sulfated polysaccharids for treatment or prevention of thromboses
US6022866A (en) * 1991-07-03 2000-02-08 Hyal Pharmaceutical Corporation Use of hyaluronic acid and forms to prevent arterial restenosis
US5811447A (en) * 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5500013A (en) 1991-10-04 1996-03-19 Scimed Life Systems, Inc. Biodegradable drug delivery vascular stent
WO1993006792A1 (en) * 1991-10-04 1993-04-15 Scimed Life Systems, Inc. Biodegradable drug delivery vascular stent
WO1993019734A1 (en) * 1992-04-02 1993-10-14 Baker Norton Pharmaceuticals, Inc. Method and composition for treating antigen-induced and exercise-induced asthma
US5460807A (en) * 1992-08-19 1995-10-24 Merrell Dow Pharmaceuticals Inc. Antiproliferative oligomers
US5958883A (en) * 1992-09-23 1999-09-28 Board Of Regents Of The University Of Washington Office Of Technology Animal models of human amyloidoses
US6306421B1 (en) 1992-09-25 2001-10-23 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US5770609A (en) * 1993-01-28 1998-06-23 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6395494B1 (en) 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
US5354774A (en) * 1992-12-24 1994-10-11 Yale University Inhibition of smooth muscle cell proliferation by 8-methoxypsoralen photoactivated by visible light
US5981568A (en) * 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5595722A (en) * 1993-01-28 1997-01-21 Neorx Corporation Method for identifying an agent which increases TGF-beta levels
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6663881B2 (en) 1993-01-28 2003-12-16 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
WO1994020512A2 (en) * 1993-03-01 1994-09-15 Glycan Pharmaceuticals, Inc. Analogs for specific oligosaccharide-protein interactions and uses therefor
FR2704861B1 (fr) * 1993-05-07 1995-07-28 Sanofi Elf Fractions d'héparine purifiées, procédé d'obtention et compositions pharmaceutiques les contenant.
US6197789B1 (en) 1995-06-07 2001-03-06 Neorx Corporation Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
DE69435137D1 (de) * 1993-05-13 2008-10-16 Poniard Pharmaceuticals Inc Prävention und behandlung von pathologien, die mit einer abnormalen proliferationglatter muskelzellen verbunden sind
US5498775A (en) * 1994-11-07 1996-03-12 American Home Products Corporation Polyanionic benzylglycosides as inhibitors of smooth muscle cell proliferation
US5565432A (en) * 1994-11-07 1996-10-15 American Home Products Corporation Smooth muscle cell proliferation inhibitors
IL115745A (en) * 1994-11-07 2000-11-21 American Home Prod Acylated benzylglycosides and pharmaceutical compositions containing them
US5665591A (en) * 1994-12-06 1997-09-09 Trustees Of Boston University Regulation of smooth muscle cell proliferation
US5643892A (en) * 1995-06-07 1997-07-01 Baker Norton Pharmaceuticals, Inc. Method of treating chronic progressive vascular diseases
EP0837868A1 (en) * 1995-06-29 1998-04-29 Pharmacia & Upjohn Aktiebolag New anticoagulants
US5980865A (en) 1995-08-18 1999-11-09 Baker Norton Pharmaceuticals, Inc. Method for treating late phase allergic reactions and inflammatory diseases
EP0998936B1 (en) * 1998-10-01 2006-03-15 Giovanni Gambaro Substances for the prevention of pathological overexpression of TGF-Beta and methods for evaluating same
US6235725B1 (en) 1998-10-30 2001-05-22 Baker Norton Pharmaceuticals, Inc. Methods and compositions for the prevention of tolerance to medications
US6291434B1 (en) 1998-11-24 2001-09-18 American Home Products Corp. Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation
US6340670B1 (en) 1998-11-24 2002-01-22 American Home Products Corporation Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
US6187755B1 (en) 1998-11-24 2001-02-13 American Home Products Corporation Benzylmaltosides as inhibitors of smooth muscle cell proliferation
US7081448B2 (en) 1998-11-24 2006-07-25 Wyeth Benzyllactobionamides as inhibitors of smooth muscle cell proliferation
US7132402B2 (en) 1998-11-24 2006-11-07 Wyeth Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation
US6362170B1 (en) 1998-11-24 2002-03-26 American Home Products Corporation Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
US6451767B1 (en) 1998-11-24 2002-09-17 Wyeth Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation
US6258784B1 (en) 1998-11-24 2001-07-10 American Home Products Corp. Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
US6664243B1 (en) 1998-11-24 2003-12-16 Wyeth Benzyllactobionamides as inhibitors of smooth muscle cell proliferation
US6339064B1 (en) 1998-11-24 2002-01-15 American Home Products Corporation Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
DE29900874U1 (de) 1999-01-20 1999-07-22 Knoll AG, 67061 Ludwigshafen Organprotektive Lösungen
US7572287B2 (en) * 2001-10-25 2009-08-11 Boston Scientific Scimed, Inc. Balloon expandable polymer stent with reduced elastic recoil
EP2284535A1 (en) 2002-03-11 2011-02-16 Momenta Pharmaceuticals, Inc. Low molecular weight heparins
JPWO2005092348A1 (ja) * 2004-03-29 2008-02-07 敏一 中村 ヘパリン様オリゴ糖含有ｈｇｆ産生促進薬剤
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
EP2526122B1 (en) * 2010-01-19 2020-06-10 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
WO2012115952A1 (en) 2011-02-21 2012-08-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
CA2005739A1 (en) 1990-06-15
DK115791D0 (da) 1991-06-14
EP0448637A1 (en) 1991-10-02
JPH04503950A (ja) 1992-07-16
WO1990006755A1 (en) 1990-06-28
US5032679A (en) 1991-07-16
AU4827490A (en) 1990-07-10
AU634199B2 (en) 1993-02-18
DK115791A (da) 1991-08-06
EP0448637A4 (en) 1991-10-30

Similar Documents

Publication Publication Date Title
BR8907831A (pt) Processo para preparar composicao de glicosamino glicosida,composicao de glicosamino glicosida,anti-corpos,composto,composicao farmaceutica,processo para diagnosticar deficiencia ou excesso de glicosamino glicosida antiproliferativa em paciente mamifero,processo para analisar nivel de fator antiproliferativo em amostra biologica,e processo para separar ions organicos de ions inorganicos
BR8606336A (pt) Derivados de pirazolina,processo para sua preparacao,composicoes inseticidas e emprego
BG46598A3 (en) Method for preparation of alpha- heterocyclic substituted tolunitriles
IT1207325B (it) Derivato di indolo,composizione farmaceutica che lo contiene e procedimento per prepararlo
IT1213379B (it) Tiazolo [4,5-c]chinoline, procedimento per la loro preparazione e composizioni farmaceutiche che le contengono.
BR8602823A (pt) Composicao de revestimento aquosa,composicao de pigmento,e processo para sua preparacao
DE3689117D1 (de) Pharmazeutische zusammensetzung mit gehalt an einer mischung von kollagen und einem antiseptischen und/oder entzuendungshemmenden wirkstoff und verfahren zu ihrer herstellung.
BR8404011A (pt) Composto,composicao herbicida,processo herbicida,e processos para produzir o dito composto
IT1156311B (it) Processo per la preparazione di composti organici
BR8603406A (pt) Composicao de revestimento condutor,processo de protecao catodica de concreto ou outros materiais de construcao e concreto condutor
BR8602472A (pt) Composto heterociclico contendo nitrogenio,processo para prepara-lo,composicao e processo para evitar ou exterminar insetos e uso do dito composto
BR8502985A (pt) Composicao e processo para o tratamento de solo
BR8500591A (pt) Composto,composicao e processo para controle de ervas daninhas
BR8800530A (pt) Aminometiltetrahidrofuranos processo para sua preparacao,composicoes praguicidas,processos para combater pragas e para preparacao de composicoes tetrahidrofuranos e processo para sua preparacao
BR8502987A (pt) Composicao e processo para o tratamento de solo
BR8602608A (pt) Derivados de fenantreno,composto,processo para a preparacao de derivados de fenantreno-diona,composicoes fungicidas,processo para combater as pragas de fungos,composicoes antifungicas e processo para a preparacao de composicoes antifungicas
IT7829642A0 (it) Composto di eritromicina, processo per la sua preparazione e composizioni contenenti detto composto che sono utili nel trattamento dell'acne.
BR8505326A (pt) Composto de pirazolina inseticida,composicao inseticida,processo para controlar insetos e processo para produzir uma pirazolina inseticida
BR8604209A (pt) Composto,processo para prepara-lo e composicao pesticida
BR8301794A (pt) Estrutura metalica para a composicao de edificacoes de um ou varios pavimentos,processo para realizar a mesma e estrutura metalica para edificacoes
BR8806010A (pt) Processo para preparacao de composto,composicao inseticida e processo para controlar insetos
IT8421520A0 (it) Processo per la preparazione dicomposti carbonilici.
BR8502655A (pt) Processo para a preparacao de fenilsulfonilureias substituidas,composicoes de tratamento de plantas,aplicacao e processo para a preparacao de composicoes
IT1095363B (it) Processo per la determinazione quantitativa di composti alluminioorganici nelle loro soluzioni
BR8606324A (pt) Processo para a preparacao de compostos,processo e composicao para o combate ou inibicao de uma infestacao de plantas de cultura

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/715 (2006.01), A61K 31/70 (2006.0